Comprehensive Longevity Assessment

A year-long personalised longevity medicine programme incorporating biological age testing, gut microbiome profiling, skin autofluorescence, epigenetics, and comprehensive metabolic diagnostics — delivered by a multidisciplinary NUHS team at Alexandra Hospital. The programme targets adults aged 35+ seeking evidence-based preventive care.

The Comprehensive Longevity Assessment at Alexandra Hospital's Healthy Longevity Research Clinic is one of Singapore's most rigorous and research-grounded anti-ageing programmes, offered through the publicly accessible HEAL (Health Enhancing Active Living) study conducted under the National University Health System (NUHS). The programme spans 12 months and involves a minimum of three clinical visits, combining standard diagnostics with cutting-edge longevity biomarkers not routinely available in conventional healthcare settings. The assessment begins with a thorough medical history review and baseline diagnostics: HbA1c, full lipid panel, liver and kidney function tests, and ECG. From this foundation, optional advanced modules expand the assessment into areas of biological ageing science. Epigenetic age testing analyses DNA methylation patterns across thousands of CpG sites to calculate a biological clock age — quantifying how fast or slow a person is ageing at the cellular level relative to their chronological age. This is one of the most powerful single indicators of longevity risk and is increasingly used in academic longevity research worldwide. Gut microbiome profiling sequences the composition of intestinal bacteria through stool analysis, providing insights into immune regulation, inflammation, metabolic efficiency, and even mental health — all of which are modifiable risk factors for healthy ageing. Skin autofluorescence measurement provides a non-invasive proxy for accumulated glycation damage in tissues, correlating with long-term cardiovascular and metabolic risk. Clinical care is delivered by a multidisciplinary team of physicians, nurses, exercise physiologists, and medical technologists. Each participant receives a personalised care plan emphasising sustainable lifestyle modifications — dietary optimisation, structured physical activity, stress management, and sleep improvement — rather than pharmacological interventions alone. Progress is tracked against baseline at each follow-up visit, enabling iterative refinement of the care plan. The HEAL study's research framework ensures that interventions are evidence-based and that outcomes contribute to the broader scientific understanding of healthy longevity in Asian populations. For participants, this means access to emerging longevity medicine at a public-sector institution with rigorous clinical governance — a rare combination in Singapore's healthcare landscape. Given the programme's depth and the NUHS affiliation, appointments currently have a 12-month or longer lead time, reflecting strong demand for research-grade longevity medicine at accessible pricing.